Showing results (311-320 of 439) with videos related to

Sort By:
Pageof 44
Clinical Pharmacology and Therapeutics|January 1, 1994
Pharmacodynamics of MK-0963, a new 5 alpha-reductase inhibitor: effects on serum androgen concentrationsJ I Schwartz, O L Laskin, C A Meeter, et al.
Nucleic Acids Research|July 11, 1983
Molecular cloning and sequencing of pheU, a gene for Escherichia coli tRNAPheI Schwartz, R A Klotsky, D Elseviers, et al.
Cardiovascular Therapeutics|March 27, 2010
Effects of multiple doses of clarithromycin on the pharmacokinetics of laropiprant in healthy subjectsYing-Hong Wang, Jules I Schwartz, Wen-Lin Luo, et al.
American Journal of Therapeutics|May 21, 2009
Influence of laropiprant, a selective prostaglandin D2 receptor 1 antagonist, on the pharmacokinetics and pharmacodynamics of warfarinJules I Schwartz, Fang Liu, Mark Stroh, et al.
Worldviews on Evidence-Based Nursing|June 21, 2025
A Multinational Observational Study of Nurse Work Wellbeing: A Research Protocol for the Caring Science International CollaborativeJohn W Nelson, Cathy I Schwartz, Theresa Williamson, et al.
Circulation|August 11, 2021
Prognostication of Asymptomatic Penetrating Aortic Ulcers: A Modern ApproachCharles DeCarlo, Christopher A Latz, Laura T Boitano, et al.
Journal of Clinical Pharmacology|October 1, 2003
An evaluation of the dose-dependent inhibition of CYP1A2 by rofecoxib using theophylline as a CYP1A2 probeKenneth Bachmann, Donald White, Luis Jauregui, et al.
Anesthesia and Analgesia|December 16, 2014
A Phase IIa, randomized, double-blind study of remimazolam (CNS 7056) versus midazolam for sedation in upper gastrointestinal endoscopyKeith M Borkett, Dennis S Riff, Howard I Schwartz, et al.
Health Affairs (Project Hope)|September 11, 2015
Noncommunicable Diseases In East Africa: Assessing The Gaps In Care And Identifying Opportunities For ImprovementTrishul Siddharthan, Kaushik Ramaiya, Gerald Yonga, et al.
Pageof 44